Search Results
Update on dasitinib from DASISION and SPIRIT2 trials for CML
SPIRIT2 trial on dasatinib for AML - safety and side effect management
Results of the Phase III DASISION trial and the future of CML treatment
Update on ENESTop: TFR in CML after discontinuing nilotinib
Sprycel Dasatinib News Interview
Successful TFR in DASFREE: dasatinib for R/R CML
Relapse After CML Treatment Discontinuation
EURO-SKI trial: cessation of TKI treatment in CML patients with deep molecular response
My CML: Episode 2 - week 1 on Sprycel
Update on ECOG-ACRIN EA9171: pembrolizumab + TKIs in patients with CML and persistent detectable MRD
Treatment-Free Remission in CML
My CML: Episode 3 - a break from Sprycel
